389
Views
50
CrossRef citations to date
0
Altmetric
Review

Preference for pharmaceutical formulation and treatment process attributes

, , , , , & show all
Pages 1385-1399 | Published online: 27 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Levy Bueno Alves, Willian Orlando Castillo-Ordoñez & Silvana Giuliatti. (2023) Virtual screening and molecular dynamics study of natural products against Rab10 for the treatment of Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics 41:14, pages 6728-6748.
Read now
Andreas Schneider, Reto Jost, Christoph Jordi & Jakob Lange. (2023) Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions. Expert Opinion on Drug Delivery 20:6, pages 815-830.
Read now
Andreas Schneider, Harald Kolrep, Hanns-Peter Horn, Christoph Jordi, Sina Gierig & Jakob Lange. (2023) Understanding patient preferences for handheld autoinjectors versus wearable large-volume injectors. Expert Opinion on Drug Delivery 20:2, pages 273-283.
Read now
Sanjay K Bajpai, M Janelle Cambron-Mellott, Oliver Will, Jiat-Ling Poon, Qianqian Wang, Beth D Mitchell, Eugenia Y Peck, Jane Babrowicz, Nedina K Raibulet, Christopher J Child & Kathleen Beusterien. (2022) Development of a Measure to Assess Attitudes Towards Nasal versus Autoinjector Glucagon Delivery Devices for Treatment of Severe Hypoglycemia. Diabetes, Metabolic Syndrome and Obesity 15, pages 3601-3615.
Read now
Naoko A Ronquest, Kyle Paret, Aaron Lucas, Malgorzata Ciepielewska & Melissa Hagan. (2022) Quantifying the Value of Introducing an Oral Drug Delivery Option for Edaravone: A Review of Analyses Evaluating the Economic Impact of Oral versus Intravenous Formulations. ClinicoEconomics and Outcomes Research 14, pages 499-511.
Read now
Chandramouli Radhakrishnan, Aida Sefidani Forough, Julie A Y Cichero, Heather E Smyth, Aisha Raidhan, Lisa M Nissen & Kathryn J Steadman. (2021) A Difficult Pill to Swallow: An Investigation of the Factors Associated with Medication Swallowing Difficulties. Patient Preference and Adherence 15, pages 29-40.
Read now
Jakob Lange, Andreas Schneider, Christoph Jordi, Michael Lau & Timothy Disher. (2021) Formative Study on the Wearability and Usability of a Large-Volume Patch Injector. Medical Devices: Evidence and Research 14, pages 363-377.
Read now
Wendy Y. Cheng, Ambika Satija, Hoi Ching Cheung, Kala Hill, Tim Wert, François Laliberté & Patrick Lefebvre. (2021) Persistence to hypomethylating agents and clinical and economic outcomes among patients with myelodysplastic syndromes. Hematology 26:1, pages 261-270.
Read now
Andreas Schneider, Philippe Mueller, Christoph Jordi, Philipp Richard, Peter Sneeringer, Ranjan Nayyar, Mary Yovanoff & Jakob Lange. (2020) Hold the device against the skin: the impact of injection duration on user’s force for handheld autoinjectors. Expert Opinion on Drug Delivery 17:2, pages 225-236.
Read now
Vivian T Thieu, Susan Robinson, Tessa Kennedy-Martin, Kristina S Boye & Luis-Emilio Garcia-Perez. (2019) Patient preferences for glucagon-like peptide 1 receptor–agonist treatment attributes. Patient Preference and Adherence 13, pages 561-576.
Read now
Anisha Guda, Steven R. Feldman & Lindsay Strowd. (2018) Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizon. Expert Opinion on Investigational Drugs 27:11, pages 931-939.
Read now

Articles from other publishers (38)

Fabrice Ruiz, Anthony Nunn, Andrea Gill, David Clapham, Nikoletta Fotaki, Smita Salunke, Anne Cram & Fiona O'Brien. (2023) A review of paediatric injectable drug delivery to inform the study of product acceptability – an introduction. European Journal of Pharmaceutics and Biopharmaceutics.
Crossref
Denise Steiner, Marius Tidau & Jan Henrik Finke. (2022) Embedding of Poorly Water-Soluble Drugs in Orodispersible Films—Comparison of Five Formulation Strategies. Pharmaceutics 15:1, pages 17.
Crossref
Wade Muncey, Danly Omil-Lima, Erin Jesse, Karishma Gupta, Ahmed ElShafei, Chad Heflick, Aram Loeb & Nannan Thirumavalavan. (2021) Assessment of public interest and current trends in testosterone replacement therapy. International Journal of Impotence Research 34:8, pages 753-756.
Crossref
Denise Steiner, Leonie V. Schumann & Heike Bunjes. (2022) Processing of Lipid Nanodispersions into Solid Powders by Spray Drying. Pharmaceutics 14:11, pages 2464.
Crossref
Eva J. Streekstra, Márton Kiss, Jeroen van den Heuvel, Johan Nicolaï, Petra van den Broek, Sanne M. B. I. Botden, Martijn W. J. Stommel, Lara van Rijssel, Anna‐Lena Ungell, Evita van de Steeg, Frans G. M. Russel & Saskia N. de Wildt. (2022) A proof of concept using the Ussing chamber methodology to study pediatric intestinal drug transport and age‐dependent differences in absorption. Clinical and Translational Science 15:10, pages 2392-2402.
Crossref
Vanita R. Aroda, Lawrence Blonde & Richard E. Pratley. (2022) A new era for oral peptides: SNAC and the development of oral semaglutide for the treatment of type 2 diabetes. Reviews in Endocrine and Metabolic Disorders 23:5, pages 979-994.
Crossref
Tatiana Chama Borges Luz, Ana Karine Sarvel de Castro, Isabela Cristina Marques, Betania Barros Cota, Jèssica de Castro Alves & Michael Robert Law. (2022) Performance of a pharmaceutical services regionalization strategy policy in Minas Gerais, Brazil: Pre-post analysis from ERAF project. Frontiers in Pharmacology 13.
Crossref
Luca Giordano, Andrea Francavilla, Corrado Lanera, Sara Urru, Paola Berchialla & Ileana Baldi. (2022) Building Infrastructure to Exploit Evidence from Patient Preference Information (PPI) Studies: A Conceptual Blueprint. Applied Sciences 12:14, pages 7278.
Crossref
Christine A. Butts, Duncan I. Hedderley, Sheridan Martell, Hannah Dinnan, Susanne Middlemiss-Kraak, Barry J. Bunn, Tony K. McGhie & Ross E. Lill. (2022) Influence of oral administration of kukoamine A on blood pressure in a rat hypertension model. PLOS ONE 17:5, pages e0267567.
Crossref
Paula Busse & Allen Kaplan. (2022) Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade. The Journal of Allergy and Clinical Immunology: In Practice 10:3, pages 716-722.
Crossref
Stella Deng, Bo Hoon Lee & Emma Ciafaloni. (2021) Parent Perceptions in Choosing Treatment for Infants With Spinal Muscular Atrophy Diagnosed Through Newborn Screening. Journal of Child Neurology 37:1, pages 43-49.
Crossref
Lie Yun Kok, Pauric Bannigan, Forugh Sanaee, James C. Evans, Michael Dunne, Maximilian Regenold, Lubabah Ahmed, David Dubins & Christine Allen. (2022) Development and pharmacokinetic evaluation of a self-nanoemulsifying drug delivery system for the oral delivery of cannabidiol. European Journal of Pharmaceutical Sciences 168, pages 106058.
Crossref
Alan Talevi. 2022. The ADME Encyclopedia. The ADME Encyclopedia 725 732 .
Denise Steiner, Jakob F. Emmendörffer & Heike Bunjes. (2021) Orodispersible Films: A Delivery Platform for Solid Lipid Nanoparticles?. Pharmaceutics 13:12, pages 2162.
Crossref
Ruchika Bajaj, Lisa B Chong, Ling Zou, Eleftheria Tsakalozou, Zhanglin Ni, Kathleen M Giacomini & Deanna L Kroetz. (2021) Interaction of Commonly Used Oral Molecular Excipients with P-glycoprotein. The AAPS Journal 23:5.
Crossref
Erin R. Weeda, Alyssa K. Muraoka, Matthew D. Brock & Jessica M. Cannon. (2021) Medication adherence to injectable glucagon‐like peptide‐1 (GLP‐1) receptor agonists dosed once weekly vs once daily in patients with type 2 diabetes: A meta‐analysis. International Journal of Clinical Practice 75:9.
Crossref
Louis S. Matza, Katelyn N. Cutts, Katie D. Stewart, Kirsi Norrbacka, Luis-Emilio García-Pérez & Kristina S. Boye. (2021) Health state utilities associated with treatment process for oral and injectable GLP-1 receptor agonists for type 2 diabetes. Quality of Life Research 30:7, pages 2033-2043.
Crossref
Andreas Andersen, Filip Krag Knop & Tina Vilsbøll. (2021) A Pharmacological and Clinical Overview of Oral Semaglutide for the Treatment of Type 2 Diabetes. Drugs 81:9, pages 1003-1030.
Crossref
Ahuja Nirmal, Kristin Sznajder, Rajendra Patil & Bushra Shaikh. (2021) Preference of inhalants over pills/injections among pulmonary tuberculosis patients in Western India: A cross-sectional study. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 23, pages 100234.
Crossref
Camilla Virili, Nunzia Brusca, Silvia Capriello & Marco Centanni. (2021) Levothyroxine Therapy in Gastric Malabsorptive Disorders. Frontiers in Endocrinology 11.
Crossref
Alan Talevi. 2021. The ADME Encyclopedia. The ADME Encyclopedia 1 8 .
Jean-Pierre Rothen, Jonas Rutishauser, Philipp N. Walter, Kurt E. Hersberger & Isabelle Arnet. (2020) Oral intermittent vitamin D substitution: influence of pharmaceutical form and dosage frequency on medication adherence: a randomized clinical trial. BMC Pharmacology and Toxicology 21:1.
Crossref
Chanakya Sharma, Samuel Whittle, Pari Delir Haghighi, Frada Burstein, Roee Sa'adon & Helen Isobel Keen. (2020) Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis. Annals of the Rheumatic Diseases 79:11, pages 1432-1437.
Crossref
John Devin Peipert, Austin G. Kulasekararaj, Anna Gaya, Saskia M. C. Langemeijer, Susan Yount, F. Ataulfo Gonzalez-Fernandez, Emilio Ojeda Gutierrez, Christa Martens, Amy Sparling, Kimberly A. Webster, David Cella, Ioannis Tomazos, Masayo Ogawa, Caroline I. Piatek, Richard Wells, Flore Sicre de Fontbrune, Alexander Röth, Lindsay Mitchell, Anita Hill & Karen Kaiser. (2020) Patient preferences and quality of life implications of ravulizumab (every 8 weeks) and eculizumab (every 2 weeks) for the treatment of paroxysmal nocturnal hemoglobinuria. PLOS ONE 15:9, pages e0237497.
Crossref
André O’Reilly Beringhs, Surya Pratap Singh, Tulio Alberto Valdez & Xiuling Lu. (2020) Sublingual indocyanine green films for non-invasive swallowing assessment and inflammation detection through NIR/SWIR optical imaging. Scientific Reports 10:1.
Crossref
Felipe Rodriguez, Sarah F. John, Eva Iniguez, Sebastian Montalvo, Karina Michael, Lyndsey White, Dong Liang, Omonike A. Olaleye & Rosa A. Maldonado. (2020) In Vitro and In Vivo Characterization of Potent Antileishmanial Methionine Aminopeptidase 1 Inhibitors . Antimicrobial Agents and Chemotherapy 64:6.
Crossref
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, Abdul W. Basit, Hannah Batchelor, Talia R. Flanagan, Ina Gesquiere, Rick Greupink, Daniel Keszthelyi, Mikko Koskinen, Christine M. Madla, Christophe Matthys, Goran Miljuš, Miriam G. Mooij, Neil Parrott, Anna-Lena Ungell, Saskia N. de Wildt, Mine Orlu, Sandra Klein & Anette Müllertz. (2020) Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 147, pages 105280.
Crossref
Krzysztof Dyrbuś, Mariusz Gąsior, Peter Penson, Kausik K. Ray & Maciej Banach. (2020) Inclisiran—New hope in the management of lipid disorders?. Journal of Clinical Lipidology 14:1, pages 16-27.
Crossref
Ennio Giulio Favalli, Marco Matucci-Cerinic & Zoltan Szekanecz. (2020) The Giants (biologicals) against the Pigmies (small molecules), pros and cons of two different approaches to the disease modifying treatment in rheumatoid arthritis. Autoimmunity Reviews 19:1, pages 102421.
Crossref
Louis S. Matza, Beatrice Osumili, Katie D. Stewart, Magaly Perez-Nieves, Jessica Jordan, Giovanni Biricolti, Ester Romoli, Serena Losi, Silvia Del Santo, Erik Spaepen, Gordon Parola, Hayley Karn & Kristina S. Boye. (2019) Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy. Diabetes Therapy 11:1, pages 319-330.
Crossref
Rosanne Janssens, Isabelle Huys, Eline van Overbeeke, Chiara Whichello, Sarah Harding, Jürgen Kübler, Juhaeri Juhaeri, Antonio Ciaglia, Steven Simoens, Hilde Stevens, Meredith Smith, Bennett Levitan, Irina Cleemput, Esther de Bekker-Grob & Jorien Veldwijk. (2019) Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review. BMC Medical Informatics and Decision Making 19:1.
Crossref
Jenny Retzler, Adam Smith, Matthew Reaney, Raj Rout & Richard Hudson. (2019) Process utilities for topical treatment in atopic dermatitis. Quality of Life Research 28:9, pages 2373-2381.
Crossref
Vikas Soekhai, Chiara Whichello, Bennett Levitan, Jorien Veldwijk, Cathy Anne Pinto, Bas Donkers, Isabelle Huys, Eline van Overbeeke, Juhaeri Juhaeri & Esther W. de Bekker-Grob. (2019) Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review. Drug Discovery Today 24:7, pages 1324-1331.
Crossref
Philipp Schreiner, Markus F. Neurath, Siew C. Ng, Emad M. El-Omar, Ala I. Sharara, Taku Kobayashi, Tadakazu Hisamatsu, Toshifumi Hibi & Gerhard Rogler. (2019) Mechanism-Based Treatment Strategies for IBD: Cytokines, Cell Adhesion Molecules, JAK Inhibitors, Gut Flora, and More. Inflammatory Intestinal Diseases 4:3, pages 79-96.
Crossref
Eline van Overbeeke, Chiara Whichello, Rosanne Janssens, Jorien Veldwijk, Irina Cleemput, Steven Simoens, Juhaeri Juhaeri, Bennett Levitan, Jürgen Kübler, Esther de Bekker-Grob & Isabelle Huys. (2019) Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discovery Today 24:1, pages 57-68.
Crossref
Farimah Rahimi, Hamid Reza Rasekh, Ezatollah Abbasian, Farzad Peiravian, Masoud Etemadifar, Fereshteh Ashtari, Ali Mohammad Sabzghabaee & Mohammad Reza Amirsadri. (2018) Patient preferences for Interferon-beta in Iran: A discrete choice experiment. PLOS ONE 13:3, pages e0193090.
Crossref
Tsung Yu, Nomin Enkh-Amgalan & Ganchimeg Zorigt. (2017) Methods to perform systematic reviews of patient preferences: a literature survey. BMC Medical Research Methodology 17:1.
Crossref
K. Steen Carlsson, E. Andersson & E. Berntorp. (2017) Preference-based valuation of treatment attributes in haemophilia A using web survey. Haemophilia 23:6, pages 894-903.
Crossref